1. Design and properties of ligand-conjugated guanine oligonucleotides for recovery of mutated G-quadruplexes

    Takahashi, S., Chelobanov, B., Kim, K. T., Kim, B. H., Stetsenko, D. & Sugimoto, N., 6 Dec 2018, In: Molecules. 23, 12, 13 p., 3228.

    Research output: Contribution to journalArticlepeer-review

  2. Data for isolation and properties analysis of diastereomers of a mono-substituted phosphoryl guanidine trideoxyribonucleotide

    Lomzov, A. A., Kupryushkin, M. S., Shernyukov, A. V., Nekrasov, M. D., Dovydenko, I. S., Stetsenko, D. A. & Pyshnyi, D. V., 1 Aug 2019, In: Data in Brief. 25, p. 104148 25 p., 104148.

    Research output: Contribution to journalArticlepeer-review

  3. CpG олигонуклеотиды с модифицированными фосфатными группами индуцируют созревание миелоидных дендритных клеток человека in vitro

    Ostanin, A. A., Leplina, O. Y., Burakova, E. A., Tyrinova, T. V., Fokina, A. A., Proskurina, A. S., Bogachev, S. S., Stetsenko, D. A. & Chernykh, E. R., 2020, In: Vavilovskii Zhurnal Genetiki i Selektsii. 24, 6, p. 653-660 8 p.

    Research output: Contribution to journalArticlepeer-review

  4. Chemistry of peptide-oligonucleotide conjugates: A review

    Klabenkova, K., Fokina, A. & Stetsenko, D., Sept 2021, In: Molecules. 26, 17, 5420.

    Research output: Contribution to journalReview articlepeer-review

  5. Application of silicon dioxide nanoparticles modified with tumor-targeting ligands for cellular delivery of nucleoside triphosphate analogues

    Vasilyeva, S. V., Petrova, A. S., Shtil, A. A. & Stetsenko, D. A., Jan 2020, In: Journal of Saudi Chemical Society. 24, 1, p. 98-104 7 p.

    Research output: Contribution to journalArticlepeer-review

  6. Antiviral Activity of Nanocomplexes of Antisense Oligonucleotides Targeting VP72 Protein in Vero Cells Infected by African Swine Fever Virus

    Hakobyan, A. V., Burakova, E. A., Arabyan, E. A., Fokina, A. A., Kotsinyan, A. R., Vasilyeva, S. V., Zakaryan, O. S. & Stetsenko, D. A., Mar 2021, In: Russian Journal of Bioorganic Chemistry. 47, 2, p. 411-419 9 p.

    Research output: Contribution to journalArticlepeer-review

  7. Antitumor efficacy of multi-target in situ vaccinations with CpG oligodeoxynucleotides, anti-OX40, anti-PD1 antibodies, and aptamers

    Proskurina, A. S., Рузанова, В. С., Риттер, Г. С., Ефремов, Я. Р., Mustafin, Z. S., Лашин, С. А., Буракова, Е. А., Фокина, А. А., Zatsepin, T. S., Стеценко, Д. А., Леплина, О. Ю., Останин, А. А., Черных, Е. Р. & Bogachev, S. S., 2023, In: Journal of Biomedical Research. 37, 3, p. 194-212 19 p.

    Research output: Contribution to journalArticlepeer-review

  8. Antisense oligonucleotide gapmers containing phosphoryl guanidine groups reverse MDR1-mediated multiple drug resistance of tumor cells

    Kupryushkin, M. S., Filatov, A. V., Mironova, N. L., Patutina, O. A., Chernikov, I. V., Chernolovskaya, E. L., Zenkova, M. A., Pyshnyi, D. V., Stetsenko, D. A., Altman, S. & Vlassov, V. V., 8 Mar 2022, In: Molecular Therapy - Nucleic Acids. 27, p. 211-226 16 p.

    Research output: Contribution to journalArticlepeer-review

  9. A new antisense phosphoryl guanidine oligo-2′-O-methylribonucleotide penetrates into intracellular mycobacteria and suppresses target gene expression

    Skvortsova, Y. V., Salina, E. G., Burakova, E. A., Bychenko, O. S., Stetsenko, D. A. & Azhikina, T. L., 19 Sept 2019, In: Frontiers in Pharmacology. 10, SEP, 1049.

    Research output: Contribution to journalArticlepeer-review

  10. Analysis of new charge-neutral DNA/RNA analogues phosphoryl guanidine oligonucleotides (PGO) by gel electrophoresis

    Fokina, A., Wang, M., Ilyina, A., Klabenkova, K., Burakova, E., Chelobanov, B. & Stetsenko, D., 15 Aug 2018, In: Analytical Biochemistry. 555, p. 9-11 3 p.

    Research output: Contribution to journalArticlepeer-review

ID: 21252425